Mezim 20000 Tablets p / o enteric, No. 20
Dosage:
137.5mg
20000ED
Category
Preparations for the gastrointestinal tract
,
Enzymes
Scope of the drug
Gastrointestinal tract
Release form
Tablet
Manufacturer country
Germany
Package quantity, pcs
twenty
Mezim 20,000 tab.
p / o No. 20
Name ENG
MEZYM FORTE 10,000
Clinical and pharmacological group
Enzyme preparation
ATX code
Multienzymes (lipase, protease etc.)
Dosage
20000ED
Structure
1 tablet contains:
Active substances: pancreatin 137.5 mg with minimal enzymatic activity: lipase 10,000 U Ph.Eur, amylase 7,500 U Ph.Eur, proteases 375 U Ph.Eur.
Excipients: lactose monohydrate, microcrystalline cellulose, colloidal silicon dioxide, crospovidone, magnesium stearate.
Shell composition: hypromellose, copolymer of methacrylic acid and ethyl acrylate (1: 1) dispersion 30% (dry weight), triethyl citrate, titanium dioxide (E171), talc, simethicone emulsion 30% (dry weight), macrogol 6000, sodium carmellose, polysorbate 80 , azorubin varnish (E122), sodium hydroxide.
Indications
Lack of exocrine pancreatic function (cystic fibrosis, chronic pancreatitis, etc.).
Chronic inflammatory-dystrophic diseases of the stomach, intestines, liver, gallbladder.
Conditions after resection or irradiation of these organs, accompanied by impaired food digestion, flatulence, diarrhea (as part of combination therapy).
To improve the digestion of food in patients with normal gastrointestinal tract function in case of nutritional deficiencies.
Preparation for X-ray and ultrasound examination of the abdominal organs.
Disorder of the gastrointestinal tract of a functional nature (with intestinal infectious diseases, irritable bowel syndrome, etc.).
Contraindications
Hypersensitivity to pancreatin or other components of the drug.
Acute pancreatitis or exacerbation of chronic pancreatitis.
Nevertheless, the appointment is acceptable in the phase of damping exacerbation with the expansion of the diet, if there are signs of digestive disorders.
Hereditary galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome.
Children under 3 years old.
INN / Active ingredient
Pancreatin
Storage conditions and periods
At a temperature not higher than 30 degrees.
Expiration date: 3 years
Specifications
Category
Preparations for the gastrointestinal tract
,
Enzymes
Scope of the drug
Gastrointestinal tract
Release form
Tablet
Manufacturer country
Germany
Package quantity, pcs
twenty
Scope of application
Gastroenterology
Minimum age from
3 years old
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Berlin-Chemie / Menarini
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Digestive Enzyme Remedy
Anatomical and therapeutic characteristics
A09AA02 Polyenzyme preparations (lipase + protease, etc.)
Dosage form
Enteric-coated tablets
Packaging
Box
Expiration date in days
1095
The target audience
Children
Package weight, g
twenty
Mode of application
:
The dose of the drug Mezim forte 10000 is set individually depending on the severity of the disease and the composition of the food. < br> Unless otherwise indicated, the average single dose for adults is 2-4 tab. Mezim forte 10,000 per meal. It is recommended to take half or a third of a single dose at the beginning of a meal, and the rest during it. The drug is taken orally without chewing and drinking a sufficient amount of liquid. It is possible to increase the dose, which should be carried out only under the supervision of a physician, focusing on the weakening of symptoms (for example, steatorrhea, abdominal pain). The maximum daily dose is 15000-20000 U Ph.Eur. lipase / kg body weight. For children, the dosage regimen is established by the doctor depending on the severity of the disease and the composition of the food at the rate of 500-1000 U Ph.Eur.lipase / kg body weight of the child for each meal. < br> The duration of treatment can vary from several days (in case of indigestion, inadequacy in the diet) to several months and even years (if constant substitution therapy is necessary). < br> < br>
Dosage (volume) of the substance in the preparation
:
Pancreatin - 220.00 - 293.34 mg with minimum activity: lipase 20,000 U of amylase 12,000 U of protease 900 U